Research & Development
27 April 2026 - Biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (NYSE: AZN) declared on Monday that it has received US Food and Drug Administration approval for the subcutaneous self-a...
27 April 2026 - Global healthcare company Abbott (NYSE:ABT) on Saturday announced new late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PF...
24 April 2026 - Swiss pharmaceutical company Novartis AG (SIX:NOVN) (NYSE:NVS) announced on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
24 April 2026 - French pharmaceutical company Servier announced on Thursday the successful completion of its tender offer to acquire all of the issued and outstanding shares of common stock of Day One...
24 April 2026 - Indian pharmaceutical company Cipla Limited (BSE:500087) (NSE:CIPLA-EQ) and its US subsidiary Cipla USA Inc announced on Thursday that the US Food and Drug Administration (FDA) has giv...
23 April 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) announced late Wednesday that the US Fo...